Unpublished data summaries and the design and conduct of clinical trials. The nutrition adjuvant study experience and commentary

Controlled Clinical Trials

Volumn 10, Issue 4, 1989, Pages 368-377

  Chlebowski, Rowan T ^{a,b,c,d,e,f,g,h,i}   Blackburn, George L ^{a,b,c,d,e,f,g,h,i}   Nixon, Daniel W ^{a,b,c,d,e,f,g,h,i}   Jochimsen, Peter ^{a,b,c,d,e,f,g,h,i}   Scanlon, Edward F ^{a,b,c,d,e,f,g,h,i}   Insull Jr , William ^{a,b,c,d,e,f,g,h,i}   Marilyn Buzzard, I ^{a,b,c,d,e,f,g,h,i}   Wynder, Ernst L ^{a,b,c,d,e,f,g,h,i}   Elashoff, Robert ^{a,b,c,d,e,f,g,h,i}  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^e Illinois Science Council   (United States)

^f Section of Atherosclerosis and Vascular Medicine   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h AMERICAN HEALTH FOUNDATION   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adjuvant breast cancer; clinical alert; consensus conference; dietary fat; meta analysis; nutrition and cancer

Indexed keywords

ARTICLE; BREAST CANCER; CHEMOTHERAPY; CLINICAL TRIAL; COMPUTER ANALYSIS; FAT INTAKE; FEMALE; HUMAN; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; METHODOLOGY; PEER REVIEW; PRIORITY JOURNAL;

BREAST NEOPLASMS; CLINICAL PROTOCOLS; DATA INTERPRETATION, STATISTICAL; DIETARY FATS; FEMALE; HUMAN; MEDICAL INFORMATICS; META-ANALYSIS; MULTICENTER STUDIES; NEOPLASM RECURRENCE, LOCAL; PEER REVIEW; PUBLISHING; RANDOMIZED CONTROLLED TRIALS; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES;

EID: 0024818776     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-2456(89)90002-0     Document Type: Article

References (28)

1. Adjuvant Chemotherapy for Breast Cancer
2. Consensus Development Conference Report Adjuvant Chemotherapy for breast cancer
3. Consensus Development Conference Report Treatment of primary breast cancer
4. Meta-analysis in clinical trials
5. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer An overview of 61 randomized trials among 28896 women
6. Five year results of a randomized clinical trial comparing mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer
7. Adjuvant chemotherapy for breast cancer: A pooled estimate based on published randomized control trials
8. Review of mortality results in randomized trials in early breast cancer
9. Meta-analyses of randomized controlled trials
10. Proceedings of methodological issues in overviews of randomized clinical trials
11. The NIH Consensus Development Conference on Adjuvant Chemotherapy for Breast Cancer—a commentary
12. The Process and Provacations of Consensus
13. Clinical trials of low fat diets and breast cancer prevention
14. Comparative clinicopathological study of breast cancer among Japanese and American women
15. A comparison of survival risks between American and Japanese patients with breast cancer
16. A breast cancer Nutrition Adjuvant study (NAS): Protocol design and initial patient adherence
17. Statistical design of the Women's Health Trial
18. Some thoughts on the future of clinical trials in cancer
19. Adjuvant chemotherapy
20. Adjuvant chemotherapy of breast cancer: A promising experiment or standard practice?
21. Adjuvant endocrine therapy of breast cancer: A controlled clinical trial of oestrogen and anti-oestrogen
22. Beneficial effect of adjuvant tamoxifen in primary breast cancer patients with high oestrogen receptor values
23. Influence of a breast cancer Nutrition Adjuvant Study (NAS) on dietary fat intake in control and intervention groups at one year
24. Patterns of the care study of breast cancer adjuvant chemotherapy
25. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer
26. Primary secondary and meta-analysis of research
27. NIH Multicenter Investigator-Initiated Trials: An Endangered Species?